|
|
|
| Mining of susceptible genes of colon cancer based on GEO |
| Zhong Yao-hong, He Qing-fang, Li Ying-jun, Ding Ye, Jing Fang-yuan, Fan Chun-hong
|
| Hangzhou Medical College,Hangzhou,Zhejiang,310053,China |
|
|
|
|
Abstract Objective To screen the key genes of colon cancer and to explore the pathogenesis of colon cancer. Methods The expression data were searched from Gene Expression Omnibus （GEO） and the differentially expressed genes were selected by GEO2R. The differentially expressed genes were analyzed by gene ontology（GO）,KEGG pathway and protein-protein interaction networks. Results A total of 324 differentially expressed genes including 61 upregulated genes and 263 downregulated genes were found in more than three GEO series. An analysis of differentially expressed gene pathways revealed that bile secretion,drug metabolism,cytochrome P450,and chemical carcinogenesis were involved in the pathogenesis of colon cancer. Thus 9 key genes were identified,including BMP2,CXCL1,CXCL12,CXCL2,GCG,IL8,MMP1,PHLPP2 and PYY. Conclusion The key genes could be screened by bioinformatics effectively,which might provide the basis for further experimental study.
|
|
Received: 08 March 2017
Revised: 14 June 2017
Published: 06 November 2017
|
|
|
|
|
|
[1] CHEN W,ZHENG R,BAADE P D,et al. Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66（2）：115- 132.
[2] JIAO X,SHERMAN B T,HUANG D W,et al. DAVID-WS：a stateful web service to facilitate gene/protein list analysis[J]. Bioinformatics,2012,28（13）：1805-1806.
[3] SZKLARCZYK D,FRANCESCHINI A,WYDER S,et al. STRING v10：protein-protein interaction networks,integrated over the tree of life[J]. Nucleic Acids Res,2015,43（Database issue）：D447-D452.
[4] RIDLON J M,WOLF P G,GASKINS H R. Taurocholic acid metabolism by gut microbes and colon cancer[J]. Gut Microbes,2016,7（3）：201-215.
[5] BEYERLE J,FREI E,STIBOROVA M,et al. Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer[J]. Drug Metab Rev,2015, 47（2）：199-221.
[6] VISHNUBLAJI R,YUE S,ALFAYEZ M,et al. Bone morphogenetic protein 2 （BMP2）induces growth suppression and enhances chemosensitivity of human colon cancer cells[J]. Cancer Cell Int,2016（16）：77.
[7] VERBEKE H,STRUYF S,LAUREYS G,et al. The expression and role of CXC chemokines in colorectal cancer[J]. Cytokine Growth Factor Rev,2011,22（5-6）：345-358.
[8] CAMPBELL J E,DRUCKER D J. Pharmacology,physiology,and mechanisms of incretin hormone action[J]. Cell Metab,2013,17（6）：819-837.
[9] DENG L,GUI Z,ZHAO L,et al. Diabetes mellitus and the incidence of colorectal cancer：an updated systematic review and meta-analysis[J]. Dig Dis Sci,2012,57（6）：1576-1585.
[10] 徐静权. 罹患结直肠癌的风险与糖尿病的临床相关性分析[D]. 太原：山西医科大学,2016.
[11] JIN W J,XU J M,XU W L,et al. Diagnostic value of interleukin-8 in colorectal cancer：a case-control study and meta-analysis[J]. World J Gastroenterol,2014,20（43）：16334-16342.
[12] LIU D,DUAN W,GUO H,et al. Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer[J]. Int J Colorectal Dis,2011,26（9）：1099-1105.
[13] LI X,STEVENS P D,LIU J,et al. PHLPP is a negative regulator of RAF1,which reduces colorectal cancer cell motility and prevents tumor progression in mice[J]. Gastroenterology,2014,146（5）：1301-1312.
[14] PRICE S L,BLOOM S R. Protein PYY and its role in metabolism[J]. Front Horm Res,2014（42）：147-154.
[15] ALOSI J A,MCFADDEN D W. Peptide YY mediates inhibition of tumor growth and inflammation[J]. Methods Mol Biol,2009（512）：377-394. |
|
|
|
